Translational Development Acquisition Corp.

NASDAQ:TDAC

Shell Companies

Financial Services
$10.88 -0.09%

-$0.01 today

Market cap
$267.99M
Beta
0.01
P/E (TTM)
29.8
EPS (TTM)
$0.36
52W Low $10.27High $10.80

Volume 0.47M

Average 0.10M

TDAC EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Translational Development Acquisition Corp.NASDAQ: TDAC

EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026

EPS (Basic) declines year over year

Q1 FY2026 EPS (Basic) of $0.06 fell 83.6% year over year, behind the -18.5% change in trailing-twelve-month EPS (Basic). Sequentially, it fell 16.5% from the prior quarter.

Context

  • EPS (Basic) increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -83.6% toward the trailing-twelve-month pace of -18.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0.06-16.5% QoQ
Last fiscal yearDec 2025
$0.37+2384.0% YoY
LTMMar 2026
$0.29-18.5% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-83.6%——
1 year+2384.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

EPS (Basic) history

USD · from the income statement

Latest · FY2025
0.37 USD
Year-over-year change
+2384.0%

EPS (Basic) vs competitors

How TDAC compares with its peers on the latest reported figures

  • TDAC's LTM Mar 2026 EPS (Basic) of $0.29 is the 3rd highest of the 7 companies compared; the peer median is $0.25.
  • Its year-over-year change of -18.5% is the 4th highest of 6, against a peer median of +134.5%.
TDAC Competitors Peer median
EPS (Basic) for TDAC and competitors
Company Period LTM YoY 3-year CAGR
HCMAHCM Acquisition CorpFY2022$552.01 +138002600.0%—
SZZLSizzle Acquisition Corp. IILTM Mar 2026$0.34 ——
TDACTranslational Development Acquisition Corp.LTM Mar 2026$0.29 -18.5%—
NTWONewbury Street II Acquisition CorpLTM Mar 2026$0.26 +134.5%—
MACIMelar Acquisition Corp. ILTM Mar 2026$0.23 -32.4%—
FACTFACT II Acquisition CorpLTM Mar 2026$0.22 +137.5%+24.5%
CEPOCantor Equity Partners I, Inc. Class A Ordinary SharesLTM Mar 2026-$0.46 -1442.9%—
Peer median (excluding TDAC) $0.25+134.5%+24.5%

Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue001.07M0
Cost of Revenue00320.87K0
Gross Profit00744.92K0
Gross Margin——69.9%—
Research & Development0000
Selling, General & Admin70.66K485.55K196.36K944.54K
Operating Expenses70.66K485.55K196.36K944.54K
Depreciation & Amortization70.66K000
EBITDA0(485.55K)(71.01K)(944.54K)
EBITDA Margin——-6.7%—
Operating Income(70.66K)(485.55K)(196.36K)(944.54K)
Operating Margin——-18.4%—
Interest Income0000
Interest Expense00508.56K0
Other Income / Expenses00125.35K7.31M
Income Before Tax(70.66K)(485.55K)(71.01K)6.36M
Pre-Tax Margin——-6.7%—
Income Tax Expense0000
Net Income(70.66K)(485.55K)(71.01K)6.36M
Net Margin——-6.7%—
EPS (Basic)(0.02)(0.12)(0.02)0.37
EPS (Diluted)(0.02)(0.12)(0.02)0.37
Weighted Avg Shares4.05M4.05M4.05M17.25M
Weighted Avg Shares (Diluted)4.05M4.05M4.05M17.25M

Translational Development Acquisition Corp.

NASDAQ:TDAC

Intrinsic Alpha fair value

Locked

Current Price

$10.88

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.